The natural history and treatment outcome of blast phase BCR-ABL(−) myeloproliferative neoplasms

We analyzed the outcomes of 74 patients diagnosed with BCR-ABL(−) myeloproliferative neoplasms in blast phase receiving induction chemotherapy (55%), low-intensity therapy (16%), stem cell transplantation (SCT; 3%), or supportive care (26%). Median survival from the date of blastic transformation wa...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Tam, Constantine S., Nussenzveig, Roberto M., Popat, Uday, Bueso-Ramos, Carlos E., Thomas, Deborah A., Cortes, Jorge A., Champlin, Richard E., Ciurea, Stefan E., Manshouri, Taghi, Pierce, Sherry M., Kantarjian, Hagop M., Verstovsek, Srdan
格式: Artigo
語言:Inglês
出版: American Society of Hematology 2008
主題:
Clinical Trials and Observations
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2518875/
https://ncbi.nlm.nih.gov/pubmed/18566326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-138230
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍